Correlation Between Virax Biolabs and 180 Life
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and 180 Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and 180 Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and 180 Life Sciences, you can compare the effects of market volatilities on Virax Biolabs and 180 Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of 180 Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and 180 Life.
Diversification Opportunities for Virax Biolabs and 180 Life
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and 180 is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and 180 Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 180 Life Sciences and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with 180 Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 180 Life Sciences has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and 180 Life go up and down completely randomly.
Pair Corralation between Virax Biolabs and 180 Life
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.33 times more return on investment than 180 Life. However, Virax Biolabs is 1.33 times more volatile than 180 Life Sciences. It trades about -0.02 of its potential returns per unit of risk. 180 Life Sciences is currently generating about -0.5 per unit of risk. If you would invest 224.00 in Virax Biolabs Group on August 31, 2024 and sell it today you would lose (17.00) from holding Virax Biolabs Group or give up 7.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. 180 Life Sciences
Performance |
| Timeline |
| Virax Biolabs Group |
| 180 Life Sciences |
Virax Biolabs and 180 Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and 180 Life
The main advantage of trading using opposite Virax Biolabs and 180 Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, 180 Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 180 Life will offset losses from the drop in 180 Life's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| 180 Life vs. Zura Bio Limited | 180 Life vs. Phio Pharmaceuticals Corp | 180 Life vs. Sonnet Biotherapeutics Holdings | 180 Life vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |